Back to Search
Start Over
Supplementary Figure S7 from Inhibition of MDSC Trafficking with SX-682, a CXCR1/2 Inhibitor, Enhances NK-Cell Immunotherapy in Head and Neck Cancer Models
- Publication Year :
- 2023
- Publisher :
- American Association for Cancer Research (AACR), 2023.
-
Abstract
- Supplemental Figure S7. SX-682 treatment does not alter PMN-MDSC suppressive capacity
Details
- Database :
- OpenAIRE
- Accession number :
- edsair.doi.dedup.....3d32e1729179b2c8191a3483bb36eac6